Haitao Li

FDA investigator

Appears on 5 documents from 2019 to 2024, mostly at sites in India. Most often cites responsibilities of quality control unit (21 CFR 211.22).

5
Documents on file
3.4
Observations per 483
2019
First seen
2024
Most recent

What they cite most

From 17 observations

Activity by year

2019: 1, 2024: 4

Where

India 3 · California 1 · Slovenia 1

Is Haitao Li coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Sun Pharmaceutical Industries LimitedMay 17, 2024 · Bharuch, India
483 CIPLA LIMITEDMay 8, 2024 · Pune, India
483 CiplaLtdMay 3, 2024 · Kurkumbh, India
483 Form 483 · FEI 3013358387Feb 9, 2024 · Ljubljana, Slovenia
483 American Regent, Inc.Jan 25, 2019 · Brea, California

About this profile

What does Haitao Li inspect?

Haitao Li appears on 5 documents on file covering 4 sites, mostly in India.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.67 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Haitao Li is dated May 17, 2024.